| Q45713868 | A novel gain-of-function mutation of the integrin alpha2 VWFA domain |
| Q28213348 | A review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes |
| Q35581561 | Adhesion molecules and atherosclerosis |
| Q73231127 | Allelic distribution of the glycoprotein Ia (alpha2-integrin) C807T/G873A dimorphisms among caucasian venous thrombosis patients and six racial groups |
| Q46892241 | An association of candidate gene haplotypes and bleeding severity in von Willebrand disease type 2A, 2B, and 2M pedigrees |
| Q48091567 | Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease |
| Q28195472 | Aspirin resistance and genetic polymorphisms |
| Q74597665 | Assessment of genetic markers for coronary thrombosis: promise and precaution |
| Q54769630 | Association of ABO histo-blood group B allele with myocardial infarction. |
| Q33653519 | Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction |
| Q46566213 | Association of polymorphisms of platelet membrane integrins alpha IIb(beta)3 (HPA-1b/Pl) and alpha2(beta)1 (alpha807TT) with premature myocardial infarction |
| Q39216044 | Bloody tears and hematohidrosis in a patient of PF3 dysfunction: a case report |
| Q34180954 | Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment |
| Q33579530 | Class prediction models of thrombocytosis using genetic biomarkers |
| Q78116307 | Contribution of the glycoprotein Ia 807TT, methylene tetrahydrofolate reductase 677TT and prothrombin 20210GA genotypes to prothrombotic risk among factor V 1691GA (Leiden) carriers |
| Q93152908 | Emerging Factors Implicated in Fibrotic Organ-Associated Thrombosis: The Case of Two Organs |
| Q41484870 | GPla Polymorphisms Are Associated with Outcomes in Patients at High Cardiovascular Risk |
| Q34459073 | Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease |
| Q37156517 | Genetic dissection of platelet function in health and disease using systems biology |
| Q35179025 | Genetic evaluation for coronary artery disease |
| Q37141815 | Genetic polymorphisms for the study of multifactorial stroke. |
| Q33988457 | Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development |
| Q33404884 | Genetic variability in platelet integrin α2β1 density: possible contributor to Plasmodium vivax-induced severe thrombocytopenia |
| Q44022855 | Genetic variants of the hemostatic system and development of transplant coronary artery disease |
| Q44739067 | Genetic variation responsible for mouse strain differences in integrin alpha 2 expression is associated with altered platelet responses to collagen |
| Q35919740 | Genetics of diabetic retinopathy. |
| Q36094351 | Genetics of platelet glycoprotein receptors: risk of thrombotic events and pharmacogenetic implications |
| Q35582345 | Glycoprotein Ia C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow up. |
| Q43631885 | Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting |
| Q46645058 | Human platelet alloantigens HPA-1, HPA-2, and HPA-3 polymorphisms associated with extent of severe coronary artery disease |
| Q44185679 | Idiopathic sudden sensorineural hearing loss: classic cardiovascular and new genetic risk factors |
| Q44802298 | Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes |
| Q38139612 | Integrin modulators: a patent review |
| Q43511406 | Integrin-independent tyrosine phosphorylation of p125(fak) in human platelets stimulated by collagen |
| Q74774336 | Iron deficiency anaemia in young women |
| Q37084956 | Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999–2004 |
| Q33915935 | Mitigation of oxygen-induced retinopathy in α2β1 integrin-deficient mice. |
| Q36843011 | Molecular genetics of myocardial infarction |
| Q35111110 | Platelet Receptors and Their Role in Diseases |
| Q35812977 | Platelet antigens and their function. |
| Q57259863 | Platelet collagen receptor GPIa (C807T/HPA-5) haplotype is not associated with an increased risk of fatal coronary events in middle-aged men |
| Q40661562 | Platelet glycoprotein Ia 807C/T (Phe224) and 873G/A (Thr246) dimorphisms in Turkey |
| Q54567673 | Platelet glycoprotein Ia 807C/T and 873G/A polymorphisms in patients with venous thromboembolism. |
| Q73815965 | Platelet glycoprotein Ia gene dimorphism alpha2-807 in malignant arrhythmia in coronary artery disease |
| Q38779365 | Platelet glycoprotein gene Ia C807T, HPA-3, and Ibα VNTR polymorphisms are associated with increased ischemic stroke risk: Evidence from a comprehensive meta-analysis |
| Q34434798 | Platelet glycoprotein gene polymorphisms and risk of thrombosis: facts and fancies |
| Q34333809 | Platelet glycoproteins and their role in diseases |
| Q74587420 | Platelet polymorphisms and ischemic heart disease: moving beyond traditional risk factors |
| Q34333860 | Platelet polymorphisms in thrombotic disorders |
| Q83907504 | Platelet receptor gain-of-function single nucleotide polymorphisms in carotid and vertebral stenosis patients |
| Q46328596 | Platelet systems biology using integrated genetic and proteomic platforms |
| Q44435123 | Platelet α2β1 integrin activation: contribution of ligand internalization and the α2-cytoplasmic domain |
| Q35848791 | Proteomic approaches to dissect platelet function: Half the story |
| Q33785709 | Review article: platelet-collagen interactions: membrane receptors and intracellular signalling pathways |
| Q35582425 | Role of platelet glycoprotein polymorphisms in cardiovascular diseases |
| Q34989717 | Single nucleotide polymorphism network: a combinatorial paradigm for risk prediction |
| Q78196560 | The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction |
| Q44040257 | The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists |
| Q34443705 | The looming polypharmacy crisis in the management of patients with heart failure. Potential solutions |
| Q28199545 | The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion |
| Q33918597 | Thrombophilia, polymorphisms, and vascular disease |
| Q47659103 | Toward optimal set of single nucleotide polymorphism investigation before IVF. |
| Q77957375 | Trimucytin, a collagen-like snake venom protein, activates platelets independent of I-domain within alpha2 subunit of alpha2beta1 integrin |
| Q43678283 | Variability in platelet responses to collagen--comparison between whole blood perfusions, traditional platelet function tests and PFA-100. |
| Q34398712 | Variants associated with common disease are not unusually differentiated in frequency across populations |
| Q42741788 | hnRNP L regulates differences in expression of mouse integrin alpha2beta1 |